BMR vs KTCC

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score prevents a full distress risk assessment. Despite a strong gross margin of 90.23% and a low Debt/Equity ratio of 0.01, the company is deeply unprofitable with negative operating and net margins of -320.04% and -146.06%, respectively. Revenue growth is minimal at 6.70% YoY, while market performance has been severely negative, with a 1-year return of -52.7%. Valuation metrics like Price/Sales of 9.47 appear high relative to peers and fundamentals, suggesting limited upside without a turnaround.

KTCC exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. While the stock appears superficially cheap with a Price/Book of 0.28 and Price/Sales of 0.07, these metrics are offset by negative revenue growth (-15.40%) and negative operating margins (-10.65%). The combination of a bearish technical trend (0/100) and deteriorating profitability suggests a classic value trap. Despite a healthy current ratio, the lack of earnings and shrinking top line make the current valuation unsustainable.